对患有与不可逆转气道变化相关的慢性支气管炎的狗的建议治疗算法:支气管切除症和/或支气管
Aurélie Lyssens1, Elodie Roels1, Cécile Clercx1
1Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
Frontiers in veterinary science
|December 1, 2025
概括
这项研究提出了治疗慢性支气管炎 (CB) 的治疗算法,同时在狗中进行支气管炎 (BE) 和支气管 (BM). 它概述了感染和非感染病例的方法,强调合理使用抗生素和抗炎疗法.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 肺部病理学 肺部病理学
背景情况:
- 狗的慢性支气管炎 (CB) 导致呼吸道炎症和粘液,可能导致支气管切开 (BE) 和支气管 (BM).
- 目前还没有标准化治疗狗CB与并发性BE和/或BM (BEBM) 的治疗方案.
研究的目的:
- 为被诊断为CB和BEBM的狗提出基于证据的治疗算法.
- 为管理这些复杂的狗呼吸系统疾病提供一个框架.
主要方法:
- 基于兽医文献和人类医学数据,开发了两种治疗算法.
- 算法根据支气管支气管洗液 (BALF) 和支气管刷样本中细菌感染的存在或不存在来区分治疗.
- 建议包括可疑感染的初始抗生素治疗 (多西环素) 和非传染性炎症的吸入性葡萄皮质激素.
主要成果:
- 对疑似细菌感染的建议一线治疗包括口服多克西环林等待培养和qPCR结果.
- 建议在非传染性炎症病例中吸入葡萄皮质类药物,在耐火性传染病例中可以辅助使用.
- 粘膜活性剂和咳抑制剂只在必要时被建议作为辅助治疗,避免常规使用.
结论:
- 拟议的算法为用BEBM管理犬类CB提供了一个起点,强调合理的抗生素使用和抗炎策略.
- 该方法旨在改善患者的治疗结果,同时降低抗菌素耐药性的风险.
- 需要进一步的研究来验证这些治疗策略的长期疗效.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
705
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
705
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Acute Respiratory Failure-V
425
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
425
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K


